Contact
Please use this form to send email to PR contact of this press release:
First Patient Dosed in Avdoralimab Phase II Clinical Trial in COVID-19 Patients With Severe Pneumonia
TO:
Please use this form to send email to PR contact of this press release:
First Patient Dosed in Avdoralimab Phase II Clinical Trial in COVID-19 Patients With Severe Pneumonia
TO: